News
// News
Latest News
Experimental Therapy SAT-3247 Shows Promise in FSHD Mouse Study
A new experimental therapy designed to support muscle regeneration...
Fulcrum Therapeutics and Sanofi collaborate to commercialize Losmapimo
Fulcrum Therapeutics Enters into a Collaboration and License...
Avidity Announces data from phase 1/2 FORTITUDE™ trial
Avidity Announces Unprecedented AOC 1020 Data from Phase 1/2...
// Events
Upcoming Events
Rare Disease Day
At the kind invitation of Dr. Alberto Malerba, Lecturer in Gene...
// Events
Past Events
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.




